Global Antacid Tablet Market Size By Type (Ca based, Mg based), By Application (In-Patient, Out-Patient), By Region, And Segment Forecasts, 2023 to 2032

The Global Antacid Tablet Market was valued at USD 7.3 billion in 2023 and is projected to reach USD 11.6 billion by 2031, growing at a CAGR of 5.9% during the forecast period of 2023–2031. Rising incidences of gastrointestinal disorders, increasing consumption of fast food and processed meals, and growing awareness regarding over-the-counter (OTC) gastrointestinal medications are key drivers of the market. Antacid tablets, known for their convenience and rapid relief from acidity, heartburn, and indigestion, remain a preferred choice among consumers across age groups.

Drivers:

1. Rising Prevalence of Acid-Related Disorders:

An increase in conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and indigestion is significantly driving demand for antacid tablets worldwide.

2. Lifestyle Changes and Dietary Habits:

Unhealthy eating habits, sedentary lifestyles, and stress have contributed to a surge in gastrointestinal complaints, boosting the use of antacid tablets for fast relief.

3. Growth in OTC Drug Market:

The growing trend of self-medication, availability of OTC medications, and expanding pharmacy chains have fueled the market for antacid tablets.

Restraints:

1. Potential Side Effects and Drug Interactions:

Long-term use of antacids may lead to complications such as constipation, diarrhea, or kidney issues, limiting consumer adoption for extended use.

2. Availability of Alternatives:

The presence of various other forms such as liquid antacids, H2 blockers, and proton pump inhibitors may slightly restrain market penetration of tablets.

Opportunity:

1. Expansion in Emerging Markets:

Rapid urbanization, increasing disposable incomes, and improved healthcare access in countries across Asia-Pacific, Latin America, and Africa present significant growth opportunities.

2. Development of Sugar-Free and Herbal Antacids:

Product innovations, such as sugar-free and natural/herbal-based antacid tablets, are gaining traction, especially among health-conscious and diabetic populations.

Market by System Type Insights:

The calcium carbonate-based antacid tablets segment dominated the market in 2023, owing to its fast action and effectiveness in neutralizing stomach acid. This segment is expected to maintain its lead, though magnesium hydroxide-based tablets are anticipated to grow at a higher rate due to fewer side effects like constipation and better tolerance among elderly consumers.

Market by End-use Insights:

The retail pharmacy segment emerged as the largest revenue contributor in 2023, driven by easy availability and widespread consumer preference for OTC medications. Meanwhile, the online pharmacy segment is forecasted to grow significantly during the period, due to increasing e-commerce penetration and doorstep delivery trends.

Market by Regional Insights:

North America held the largest market share in 2023, attributed to a high prevalence of gastrointestinal disorders, consumer awareness, and robust OTC drug infrastructure. However, Asia-Pacific is expected to witness the fastest growth, driven by dietary shifts, rising healthcare awareness, and growth of retail and online pharmaceutical channels in countries like India and China.

Competitive Scenario:

Leading players in the Global Antacid Tablet Market include Pfizer Inc., Bayer AG, GSK plc, Sanofi S.A., Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries Ltd., Procter & Gamble Co., Takeda Pharmaceutical Company Limited, Prestige Consumer Healthcare Inc., and Cipla Ltd. These companies are investing in R&D, brand promotion, and new product launches to capture greater market share.

Key Developments:

2023: Bayer AG launched a fast-dissolving calcium carbonate tablet with natural mint flavor for improved consumer appeal.

2024: GSK expanded its TUMS range by introducing a travel-friendly pack in response to increasing consumer mobility.

2025: Dr. Reddy’s entered into a strategic partnership with a leading e-pharmacy platform to boost online sales of antacid tablets in Asia.

Scope of Work – Global Antacid Tablet Market

Key Market Developments:

Bayer AG (2023): Introduced a new variant of chewable antacid tablets with natural ingredients.

GSK (2024): Rolled out compact, travel-sized antacid packaging for on-the-go consumers.

Sanofi (2025): Collaborated with wellness influencers to promote its antacid product line via digital marketing campaigns.

FAQs:

1) What is the current market size of the Global Antacid Tablet Market?

The Global Antacid Tablet Market was valued at USD 7.3 billion in 2023.

2) What is the major growth driver of the Global Antacid Tablet Market?

The market is primarily driven by the increasing prevalence of acid reflux and gastrointestinal disorders.

3) Which is the largest region during the forecast period in the Global Antacid Tablet Market?

North America is currently the largest region, though Asia-Pacific is expected to grow fastest.

4) Which segment accounted for the largest market share in the Global Antacid Tablet Market?

The calcium carbonate-based antacid tablets segment held the largest market share in 2023.

5) Who are the key market players in the Global Antacid Tablet Market?

Major players include Pfizer, Bayer, GSK, Sanofi, Dr. Reddy’s, and Sun Pharma, among others.